-
Mashup Score: 0Capital in the Twenty-First Century - Wikipedia - 10 month(s) ago
Capital in the Twenty-First Century (French: Le Capital au XXIe siècle) is a book written by French economist Thomas Piketty. It focuses on wealth and income inequality in Europe and the United States since the 18th century. It was initially published in French (as Le Capital au XXIe siècle) in August 2013; an English translation by Arthur Goldhammer followed in April 2014.[1]Capital in the…
Source: en.m.wikipedia.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Europeans Are Becoming Poorer. ‘Yes, We’re All Worse Off.’ - 10 month(s) ago
An aging population that values its free time set the stage for economic stagnation. Then came Covid-19 and Russia’s war in Ukraine.
Source: WSJCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Application of portfolio optimization to drug discovery - 10 month(s) ago
In this work, a problem of selecting a subset of molecules, which are potential lead candidates for drug discovery, is considered. Such molecule subse…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
High treatment prices of new cancer drugs are a global public health challenge to patients and healthcare systems. Policymakers in the US and Europe a…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Evaluating Relapse-Free Survival as an Endpoint for Overall Survival in Adjuvant Immunotherapy Trials - 10 month(s) ago
AbstractBackground. Relapse-free survival (RFS) has been considered a primary endpoint to assess the effects of immunotherapy in the adjuvant setting among pati
Source: OUP AcademicCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Bayes Factor Meta-Analysis of the Mortality Claim for Peripheral Paclitaxel-Eluting Devices - 10 month(s) ago
The aim of the present study was to quantify the probability of increased mortality with paclitaxel compared with control in a dataset of 28 randomize…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Factors Affecting Success of New Drug Clinical Trials - Therapeutic Innovation & Regulatory Science - 10 month(s) ago
Clinical trials are an essential process in the development of new drugs. In spite of time-consuming processes and high costs, the overall success rate of clinical trials is only 7.9%, which is a high risk for biopharmaceutical companies. However, despite these huge risks, research on finding factors affecting clinical trials to overcome and manage to risks has been insufficient. Considering…
Source: SpringerLinkCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 8How to Know If You Talk Too Much - 10 month(s) ago
Try not to go on for more than 40 seconds at a time.
Source: Harvard Business ReviewCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0How to Retire Better, From Retirees Who Learned the Hard Way - 10 month(s) ago
Regrets offer insights that can help people think and plan better at every life stage.
Source: WSJCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 12What Having a “Growth Mindset” Actually Means - 10 month(s) ago
Debunking three common misconceptions.
Source: Harvard Business ReviewCategories: Hem/Oncs, Latest HeadlinesTweet
Source r>g https://t.co/JgNqfjqxy0